Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Medical Treatments in MBC HER2 Negative Patients in Italy - Observational Study

NCT02365831 is registered in ClinicalTrials.gov with Consorzio Oncotech as lead sponsor.

NCT NCT02365831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02365831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Medical Treatments in MBC HER2 Negative Patients in Italy - Observational Study
Lead sponsor
Consorzio Oncotech
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2015
Completion date
December 31, 2017
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer